WDR5-Myc axis promotes the progression of glioblastoma and neuroblastoma by transcriptional activating CARM1

The WD repeat domain 5 (WDR5), also known as SWD3 and BIG-3, is often overexpressed in cancers, however its molecular function in cancer remains to be elucidated. In this study, we found that WDR5 promoted the proliferation and self-renewal of glioblastoma and neuroblastoma cells. The data from data...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemical and biophysical research communications 2020-03, Vol.523 (3), p.699-706
Hauptverfasser: Wang, Feng, Zhang, Jiayi, Ke, Xiaoxue, Peng, Wen, Zhao, Gaichao, Peng, Shihan, Xu, Jie, Xu, Bo, Cui, Hongjuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The WD repeat domain 5 (WDR5), also known as SWD3 and BIG-3, is often overexpressed in cancers, however its molecular function in cancer remains to be elucidated. In this study, we found that WDR5 promoted the proliferation and self-renewal of glioblastoma and neuroblastoma cells. The data from databases and Western blot assay showed that CARM1 is a downstream gene of WDR5-Myc axis. In addition, we observed that WDR5 promoted the binding of Myc to CARM1 promoter by interacting with Myc and inducing histone 3 lysine 4 trimethylation (H3K4me3). Dual luciferase reporter system indicated that Myc binds to the upstream region (−520 to −515) before transcription start site (TSS) of CARM1 promoter. These findings suggest a novel regulatory model for the proliferation and tumorigenesis of glioblastoma and neuroblastoma by WDR5-Myc axis. •WDR5 promotes the proliferation and self-renewal of glioblastoma and neuroblastoma.•WDR5-Myc axis participates in the transcriptional regulation of CARM1 by binding to the upstream region (−520 to −515) before transcription start site (TSS) of CARM1 promoter.•CARM1 is essential for sustaining the proliferation of glioblastoma and neuroblastoma.
ISSN:0006-291X
1090-2104
DOI:10.1016/j.bbrc.2019.12.101